These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 17309644

  • 21. Dilemmas of anonymous predictive testing for Huntington disease: privacy vs. optimal care.
    Burgess MM, Adam S, Bloch M, Hayden MR.
    Am J Med Genet; 1997 Aug 08; 71(2):197-201. PubMed ID: 9217222
    [Abstract] [Full Text] [Related]

  • 22. Huntington's disease.
    Craufurd D.
    Prenat Diagn; 1996 Dec 08; 16(13):1237-45. PubMed ID: 9061754
    [Abstract] [Full Text] [Related]

  • 23. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.
    Babul R, Adam S, Kremer B, Dufrasne S, Wiggins S, Huggins M, Theilmann J, Bloch M, Hayden MR.
    JAMA; 1993 Nov 17; 270(19):2321-5. PubMed ID: 8230594
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Reluctance to undergo predictive testing: the case of Huntington disease.
    Quaid KA, Morris M.
    Am J Med Genet; 1993 Jan 01; 45(1):41-5. PubMed ID: 8418657
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Understanding the decision to take the predictive test for Huntington disease.
    Meissen GJ, Mastromauro CA, Kiely DK, McNamara DS, Myers RH.
    Am J Med Genet; 1991 Jun 15; 39(4):404-10. PubMed ID: 1678928
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. 'You don't make genetic test decisions from one day to the next'--using time to preserve moral space.
    Scully JL, Porz R, Rehmann-Sutter C.
    Bioethics; 2007 May 15; 21(4):208-17. PubMed ID: 17845479
    [Abstract] [Full Text] [Related]

  • 31. Beyond the patient: the broader impact of genetic discrimination among individuals at risk of Huntington disease.
    Bombard Y, Palin J, Friedman JM, Veenstra G, Creighton S, Bottorff JL, Hayden MR, Canadian Respond-HD Collaborative Research Group.
    Am J Med Genet B Neuropsychiatr Genet; 2012 Mar 15; 159B(2):217-26. PubMed ID: 22231990
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anthropometric discrimination among affected, at-risk, and not-at-risk individuals in families with Huntington disease.
    Farrer LA, Yu PL.
    Am J Med Genet; 1985 Jun 15; 21(2):307-16. PubMed ID: 3160237
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Presymptomatic testing for Huntington's disease by linkage and by direct mutation analysis: comparison of uptake of testing and characteristics of test applicants.
    Holloway SM, Porteous ME, Fitzpatrick DR, Crosbie AE, Cetnarskyj R, Warner J, Barron L.
    Genet Couns; 1998 Jun 15; 9(2):103-11. PubMed ID: 9664206
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.